Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications
Author Correction to "Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%) [Canadian Journal of Cardiology, Volume 41, Issue 10, Pages 1857-1874. DOI: 10.1016/j.cjca.2025.07.027]".
Journal: The Canadian journal of cardiology
Published: April 09, 2026
Post-Transplant Cyclophosphamide in Allogeneic Stem Cell Transplantation: Balancing Proven Clinical Benefits and Cardiotoxicity.
Journal: The Canadian journal of cardiology
Published: April 05, 2026
Global trend and predictors of non-labelled sacubitril-valsartan dosing: results from IKNOW-HF survey.
Journal: ESC heart failure
Published: March 26, 2026
Primary graft dysfunction after heart transplantation: Impaired metabolic recovery as an emerging mechanism.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: March 16, 2026
Author Correction to Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%): [Canadian Journal of Cardiology. Volume 41, Issue 10, Pages 1857-1874. DOI:10.1016/j.cjca.2025.07.027].
Journal: The Canadian journal of cardiology
Published: January 01, 2026
Corrigendum to Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%).: Volume 41, Issue 10, October 2025, Pages 1857-74.
Journal: The Canadian journal of cardiology
Published: December 21, 2025
The Canadian Heart Failure Society (CHFS) Workforce Committee Report 2024: Addressing the Challenges Facing the Heart Failure Physicians Workforce in Canada CHFS 2024 Heart Failure Workforce Report.
Journal: Journal of cardiac failure
Published: August 27, 2025
The Canadian Heart Failure Society (CHFS) Workforce Committee Report 2024: Addressing the Challenges Facing the Heart Failure Physicians Workforce in Canada CHFS 2024 Heart Failure Workforce Report.
Journal: Journal of cardiac failure
Published: August 27, 2025
Cardiac adverse events associated with remdesivir in COVID-19 patients: a systematic review and meta-analysis of randomised controlled trials.
Journal: BMJ open
Published: July 18, 2025
Predictive Models Aid Prognostication: Secondary Analysis Integrating Model and Physician Prognostic Estimates in Heart Failure.
Journal: JACC. Advances
Published: April 22, 2025
Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%).
Journal: The Canadian journal of cardiology
Published: March 10, 2025
Last Updated: 09/26/2026